SAB Biotherapeutics, Inc. (SABS) Earnings Call Transcripts

2 earnings calls from May 2026 to August 6, 2026

NasdaqCM US Health Care Biotechnology

About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc. (SABS) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 2 calls on record spanning May 12, 2026 to August 6, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 2 SAB Biotherapeutics, Inc. earnings call transcripts on record, spanning May 12, 2026 to August 6, 2026. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
SABS
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
2
First call
May 12, 2026
Most recent
August 6, 2026
Quarter Date
Q2 FY2026 Aug 6, 2026 Read transcript
Q1 FY2026 May 12, 2026 Read transcript